Novel insulin/IGF/relaxin family polypeptides and DNAs thereof

Details for Australian Patent Application No. 2001248809 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Ogi, Kazuhiro; Harada, Masataka; Kizawa, Hideki; Nishi, Kazunori; Suzuki, Nobuhiro; Itoh, Yasuaki

Agent Griffith Hack

Pub. Number AU-B-2001248809

PCT Pub. Number WO01/81562

Priority 2000-247962 10.08.00 JP; 2000-205587 03.07.00 JP; 2000-126340 21.04.00 JP; 2000-395050 22.12.00 JP

Filing date 20 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 19 May 2005

International Classifications

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61P 017/00 Drugs for dermatological disorders

A61P 011/00 Drugs for disorders of the respiratory system

A61P 001/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 037/00 Drugs for immunological or allergic disorders

A61P 025/00 Drugs for disorders of the nervous system

A61P 005/00 Drugs for disorders of the endocrine system

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 019/00 Drugs for skeletal disorders

A61P 003/00 Drugs for disorders of the metabolism

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 038/30 Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61K 038/28 Medicinal preparations containing peptides - Insulins

A61K 038/17 Medicinal preparations containing peptides - from animals

C12P 021/08 Preparation of peptides or proteins - Monoclonal antibodies

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C07K 016/26 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 014/65 Peptides having more than 20 amino acids

Event Publications

20 January 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant to Takeda Pharmaceutical Company Limited 2002

19 May 2005 Application Accepted

  Published as AU-B-2001248809

15 September 2005 Standard Patent Sealed

14 December 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001248811

2001248807-Fire-Extinguishing Agent, Water for Fire Extinguishing, and Method of Fire Extinguishing